+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-08-02Number of Pages: 93

Cardiovascular Monitoring and Diagnostic Devices Market (Product - ECG Systems (Resting ECG, Stress ECG), Event Monitors, Holter Monitors, Implantable Loop Recorders, ECG Management Systems) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Being the leading cause of death and witnessing a high rise in prevalence, the class of ailments that come under the purview of cardiovascular diseases is witnessing increased focus from healthcare, research, and government bodies alike. A large number of companies are venturing into the market with an innovative range of products for diagnosing and treating a variety of cardiovascular diseases. Research and development activities are being granted increasingly more funds and governments bodies are implementing various health schemes aimed at reducing the prevalence and improving awareness about cardiovascular diseases.

Transparency Market Research states that the global cardiovascular monitoring and diagnostic devices market held an opportunity of US$1.8 bn in 2015. The market is expected to expand at a 6.4% CAGR over the period between 2016 and 2024, and rise to a valuation of US$3.1 bn by 2024.

Electrocardiogram (ECG) Systems Lead on Account of Cost Effectiveness and High Efficiency

The product segment of ECG systems presently holds the largest share in the global cardiovascular monitoring and diagnostic devices market. The widespread presence and high preference for ECG systems in developed and developing regions alike are key to the segment’s leading market position. ECG systems are expected to remain the key contributor to the market’s overall revenues over 206 and 2024 as well, expanding at a 6.3% CAGR in the global market.

However, the segment of implantable loop recorders is expected to witness the fastest expansion, a 7.1% CAGR from 2016 to 2024. The segment is projected to benefit from the rising awareness about the use of these devices in diagnosing syncope. As several cases of the disease remain undiagnosed when other conventional diagnostic methods are used, implantable loop recorders are gaining an increased level of adoption across medical diagnostic centers globally. The valuation of the segment is expected to reach US$152.7 mn by 2024.

The segment of Holter monitors also holds immense growth promise owing to the rising prevalence of conditions such as arrhythmia and conduction block. The segment was valued at US$416.1 mn in 2015 and is expected to expand at a high single-digit CAGR from 2016 to 2024.

cardiovascular-monitoring-diagnostic-devices-market

 

North America to Continue Taking Largest Share of Pie but Emerging Economies Hold More Promise

North America accounted for the largest share of the overall revenues of the global cardiovascular monitoring and diagnostic devices market in 2015. The region is expected to remain the largest market over the period between 2016 and 2024 as well. Factors such as favorable reimbursement policies, high awareness about available diagnosis and treatment methods among patients and physicians, favorable reimbursement policies, and efficient healthcare infrastructure are factors that will help North America remain at the forefront of the global market. Europe, the second largest contributor to the global cardiovascular monitoring and diagnostic devices market in 2015, will also remain a lucrative owing to large scale healthcare infrastructure development activities and rising prevalence of cardiovascular disease.

However, developing regions such as Latin America and Asia Pacific will present the most promising growth opportunities for the global cardiovascular monitoring and diagnostic devices market over the period between 2016 and 2024. The presence of vast untapped growth prospects, rising healthcare expenditure, and increasing awareness about the efficiency of available techniques and devices in effectively curing several cardiovascular conditions will remain key to the overall growth of the market.

Several research studies also state that the risk of cardiovascular diseases is substantially high in mid- and low-income economies. This substantiates the fact that a large variety of cardiovascular monitoring and diagnostic devices will be consumed in Asia Pacific and Latin America in the next few years. The market for these devices will expand at a 7.5% in Asia Pacific and a 7.3% CAGR in Latin America over the period between 2016 and 2024.

In the highly dynamic global market for cardiovascular monitoring and diagnostic devices market, the top two vendors, GE Healthcare and Philips Healthcare accounted for a more than 55% of the global market in 2015. Other key vendors in the market are Spacelabs Healthcare, St. Jude Medical, Inc., and Siemens Healthcare.

1. Preface
     1.1. Report Description
     1.2. Market Segmentation
     1.3. Research Methodology

2. Executive Summary
     2.1. Global Cardiovascular Monitoring and Diagnosis Devices Market Share, by Geography, 2013–2024 (US$ Mn)
     2.2. Global Cardiovascular Monitoring and Diagnosis Devices Market, by Product Type, 2015 (US$ Mn)
     2.3. Global Cardiovascular Monitoring and Diagnosis Devices Market, by Geography, 2015 and 2024 (Value %)
     2.4. Cardiovascular Monitoring and Diagnosis Devices: Market Snapshot

3. Industry Analysis: Cardiovascular Monitoring and Diagnosis Devices Market
     3.1. Industry Overview
     3.2. Market Drivers
     3.3. Market Restraints
     3.4. Market Opportunities
     3.5. Porter’s Five Forces Analysis
     3.6. Market Attractiveness 
     3.7. Market Positioning of Key Players, (Value %) (2015)
     3.8. Recommendations 
     3.9. Global Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Product Type, 2013-2024 (US$ Mn)
            3.9.1. Introduction
            3.9.2. ECG Systems
                     3.9.2.1. Resting ECG Systems
                     3.9.2.2. Stress ECG Systems
            3.9.3. Event Monitors
            3.9.4. Holter Monitors
            3.9.5. Implantable Loop Recorders
            3.9.6. ECG Management Systems

4. Global Cardiovascular Monitoring and Diagnosis Devices Market Share, by Geography
     4.1. Introduction: Global Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.2. North America Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.3. Europe Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.4. Asia Pacific Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.5. Latin America Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.6. Rest of World Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)

5. Company Profiles
     5.1. Boston Scientific Corporation
            5.1.1. Company Overview
            5.1.2. Product Portfolio
            5.1.3. Financial Overview
            5.1.4. Product Portfolio
            5.1.5. Recent Developments
     5.2. Fukuda Denshi Co. Ltd.
            5.2.1. Company Overview
            5.2.2. Product Portfolio
            5.2.3. Financial Overview
            5.2.4. Product Portfolio
            5.2.5. Recent Developments
     5.3. GE Healthcare
            5.3.1. Company Overview
            5.3.2. Product Portfolio
            5.3.3. Financial Overview
            5.3.4. Product Portfolio
            5.3.5. Recent Developments
     5.4. Hill-Rom Holdings, Inc.
            5.4.1. Company Overview
            5.4.2. Product Portfolio
            5.4.3. Financial Overview
            5.4.4. Product Portfolio
            5.4.5. Recent Developments
     5.5. Johnson & Johnson
            5.5.1. Company Overview
            5.5.2. Product Portfolio
            5.5.3. Financial Overview
            5.5.4. Product Portfolio
            5.5.5. Recent Developments
     5.6. LivaNova PLC
            5.6.1. Company Overview
            5.6.2. Product Portfolio
            5.6.3. Financial Overview
            5.6.4. Product Portfolio
            5.6.5. Recent Developments
     5.7. Medtronic plc
            5.7.1. Company Overview
            5.7.2. Product Portfolio
            5.7.3. Financial Overview
            5.7.4. Product Portfolio
            5.7.5. Recent Developments
     5.8. Nihon Kohden Corporation
            5.8.1. Company Overview
            5.8.2. Product Portfolio
            5.8.3. Financial Overview
            5.8.4. Product Portfolio
            5.8.5. Recent Developments
     5.9. Philips Healthcare
            5.9.1. Company Overview
            5.9.2. Product Portfolio
            5.9.3. Financial Overview
            5.9.4. Product Portfolio Company Overview
            5.9.5. Product Portfolio
            5.9.6. Financial Overview
            5.9.7. Product Portfolio
            5.9.8. Recent Developments
            5.9.9. Recent Developments
     5.10. Siemens Healthcare
            5.10.1. Company Overview
            5.10.2. Product Portfolio
            5.10.3. Financial Overview
            5.10.4. Product Portfolio
            5.10.5. Recent Developments
     5.11. Spacelabs Healthcare (OSI Systems, Inc.)
            5.11.1. Company Overview
            5.11.2. Product Portfolio
            5.11.3. Financial Overview
            5.11.4. Product Portfolio
            5.11.5. Recent Developments
     5.12. St. Jude Medical, Inc.,
            5.12.1. Company Overview
            5.12.2. Product Portfolio
            5.12.3. Financial Overview
            5.12.4. Product Portfolio
            5.12.5. Recent Developments

List of Figures

FIG 1. Market Segmentation
FIG 2. Global Cardiovascular Monitoring and Diagnostic Devices Market, Estimates and Forecast, by Revenue, (US$ Mn), 2013–2024
FIG 3. Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type, (US$ Mn), 2015
FIG 4. Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography, (Value %), 2015 and 2024
FIG 5. St. Jude Medical HeartMate 3 (Left Ventricular Assist System)
FIG 6. Global Population, by Age group (%) 2000
FIG 7. Global Population, by Age group (%) 2050
FIG 8. Porter’s Five Forces Analysis: Cardiovascular Monitoring and Diagnostic Devices Market
FIG 9. Market Attractiveness Analysis - Cardiovascular Monitoring and Diagnostic Devices Market
FIG 10. Market Share of Companies, Cardiovascular Monitoring and Diagnostic Devices (%) (2015)
FIG 11. Global Resting ECG Systems Market Revenue, (US$ Mn), 2013–2024
FIG 12. Global Stress ECG Systems Market Revenue, (US$ Mn), 2013–2024
FIG 13. Global Event Monitors Market Revenue, (US$ Mn), 2013–2024
FIG 14. Global Holter Monitors Market Revenue, (US$ Mn), 2013–2024
FIG 15. Global Implantable Loop Recorders Market Revenue, (US$ Mn), 2013–2024
FIG 16. Global ECG Management Systems Market Revenue, (US$ Mn), 2013–2024
FIG 17. Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, (US$ Mn), 2013–2024
FIG 18. Boston Scientific Corporation Financial Overview (US$ Mn), 2013–2015
FIG 19. Fukuda Denshi Co., Ltd. Financial Overview (US$ Mn), 2013–2015
FIG 20. GE Healthcare Financial Overview (US$ Mn), 2013–2015
FIG 21. Hill-Rom Holdings, Inc. Financial Overview (US$ Mn), 2013–2015
FIG 22. Johnson & Johnson Financial Overview (US$ Mn), 2013–2015
FIG 23. Medtronic plc Financial Overview (US$ Mn), 2013–2015
FIG 24. Nihon Kohden Corporation Financial Overview (US$ Mn), 2013–2015
FIG 25. Philips Healthcare Financial Overview: (US$ Mn), 2013–2015
FIG 26. Siemens Healthcare Financial Overview (US$ Mn), 2013–2015
FIG 27. Spacelabs Healthcare Financial Overview (US$ Mn), 2013–2015
FIG 28. St. Jude Medical, Inc. Financial Overview (US$ Mn), 2013–2015

List of Tables

TABLE 1: Cardiovascular Monitoring and Diagnostic Devices Market Snapshot
TABLE 2: Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type, (US$ Mn), 2013–2024
TABLE 3: Global ECG Systems Market Revenue (US$ Mn), 2013–2024
TABLE 4: Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Geography, (US$ Mn), 2013–2024
TABLE 5: North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 6: North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 7: Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 8: Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 9: Asia Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 10: Asia Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 11: Latin America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 12: Latin America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 13: Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024

This report on the cardiovascular monitoring and diagnostic devices market analyzes the current and future scenario of the global market. Stroke, heart failure, and other prominent cardiovascular diseases are increasing the usage of cardiovascular monitoring and diagnostic devices. Rising geriatric population and unhealthy diet are the major drivers of the global cardiovascular monitoring and diagnostic devices market.

The cardiovascular monitoring and diagnostic devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about different segments of the market. It also provides information and data analysis of the global market with respect to the segments based on products and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global cardiovascular monitoring and diagnostic devices market.

Based on product, the market has been segmented into ECG systems, event monitors, Holter monitors, implantable loop recorders, and ECG management systems. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Geographically, the global cardiovascular monitoring and diagnostic devices market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, and Rest of Europe), Asia Pacific (Japan, China, India, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of the World. The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global cardiovascular monitoring and diagnostic devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Boston Scientific Corporation, Fukuda Denshi Co. Ltd., GE Healthcare, Hill-Rom Holdings, Inc., Johnson & Johnson, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Philips Healthcare, Siemens Healthcare, Spacelabs Healthcare (OSI Systems, Inc.), and St. Jude Medical, Inc., among others.

The global cardiovascular monitoring and diagnostic devices market has been segmented as follows:

  • Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product
    • ECG Systems
      • Resting ECG
      • Stress ECG
    • Event Monitors
    • Holter Monitors
    • Implantable Loop Recorders
    • ECG Management Systems
  • Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • India
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Rest of World


 
 
Back To Top